Compare Mechanisms, Doses & Costs Before You Switch
Which Is Best Mounjaro or Wegovy: Understanding the Switch & Save Advantage
When evaluating which is best Mounjaro or Wegovy for your weight management goals, the ability to switch medications provides significant therapeutic flexibility. Mounjaro (tirzepatide) operates as a dual GIP and GLP-1 receptor agonist, while Wegovy (semaglutide) functions as a single GLP-1 receptor agonist, offering different approaches to appetite regulation and metabolic support. At EverydayMeds, we recognise that patients may need to transition between these treatments based on individual response, side effect profiles, or cost considerations.
The Switch & Save approach means you're not locked into one medication pathway—both Wegovy and Mounjaro are available from EverydayMeds, allowing seamless transitions under prescriber guidance. Whether you're experiencing suboptimal results, encountering tolerance issues, or seeking cost-effective alternatives, having access to both treatments through our GPhC-registered pharmacy (#9012878) eliminates the complexity of changing suppliers. Your clinical journey remains uninterrupted, with consistent cold-chain delivery and expert support throughout any medication transition.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison for Smart Switching
Understanding the cost implications when deciding which is best Mounjaro or Wegovy requires examining both medications' pricing structures at EverydayMeds. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first two months' supply, while the Progress Trio (0.5mg, 1mg & 1.7mg) offers three doses for £369.99.
New customers apply code FIRST40 at checkout for additional savings, while returning customers use DOSE25 to reduce their total cost. Bundle options like the Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) at £269.99 support slower dose escalation protocols, particularly beneficial when switching from Mounjaro to Wegovy. The Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, ensuring consistent treatment without frequent reordering—ideal for patients who've successfully transitioned and found their optimal therapeutic dose.
Clinical Evidence: Which Is Best Mounjaro or Wegovy Based on STEP Trial Data
The STEP clinical trial programme demonstrates Wegovy's efficacy as a prescription-only medicine for weight management alongside a reduced-calorie diet and increased physical activity. In STEP 1, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, while STEP 5 showed sustained 15.2% weight reduction at 2 years (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial reported a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
When considering which is best Mounjaro or Wegovy, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and populations. Both medications have demonstrated significant efficacy in their respective clinical programmes, making the choice highly individual based on patient factors, tolerability, and response patterns. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment approach aligns best with your clinical profile and weight management objectives.
How Wegovy Works: GLP-1 Mechanism for Appetite Control
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a natural hormone released after eating. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, helping patients feel fuller after smaller meals and potentially reducing food cravings throughout the day. The once-weekly injection provides sustained appetite regulation, supporting adherence to reduced-calorie dietary plans essential for successful weight management. Unlike rapid-acting appetite suppressants, Wegovy's GLP-1 action promotes gradual, sustainable changes in eating patterns. The medication works alongside lifestyle modifications rather than replacing the need for dietary changes and increased physical activity, creating a comprehensive approach to long-term weight management success.
EverydayMeds Ordering Process: From Assessment to Delivery
Starting Wegovy through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine safely and efficiently. Our qualified prescribers review your submission within 3 working days (or 24 hours with express service), ensuring thorough clinical oversight before approving treatment. Once approved, your Wegovy pen ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity from our GPhC-registered pharmacy (#9012878) to your door. All deliveries include storage instructions, injection guidance, and direct access to our clinical support team for ongoing questions. The streamlined process eliminates traditional pharmacy visits while maintaining rigorous safety standards and clinical accountability throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro Logistics
Wegovy offers practical storage advantages when determining which is best Mounjaro or Wegovy for your lifestyle needs, particularly regarding travel and temperature stability. The pre-filled FlexTouch pen requires refrigeration at 2-8°C before first use but maintains stability for up to 6 weeks at room temperature below 30°C once removed from the fridge. This extended room temperature storage exceeds Mounjaro's 21-day limit, providing greater flexibility for business travel, holidays, or situations where consistent refrigeration isn't available. The dose escalation schedule progresses monthly from 0.25mg through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose, allowing gradual tolerance development. Each pen delivers four weeks of once-weekly injections, and the escalation protocol cannot be accelerated or modified without prescriber guidance to ensure optimal safety and efficacy outcomes.
Switching Protocols: Which Is Best Mounjaro or Wegovy for Medication Transitions
Patient switching between Mounjaro and Wegovy requires careful consideration of dose equivalencies, washout periods, and individual tolerance factors that influence treatment success. While direct conversion charts don't exist due to different mechanisms of action, prescribers typically recommend starting Wegovy at the standard 0.25mg dose regardless of previous Mounjaro dosing, allowing proper tolerance assessment for the GLP-1-specific mechanism. The transition period may involve temporary appetite changes as your system adjusts from dual GIP/GLP-1 activity to single GLP-1 receptor stimulation.
EverydayMeds supports seamless switching by stocking both medications and coordinating timing between your final Mounjaro dose and initial Wegovy prescription. Common switching reasons include cost optimisation, side effect management, or availability concerns—all valid clinical considerations that our prescribers address during consultation. The key advantage of switching within our pharmacy network means consistent cold-chain delivery, familiar ordering processes, and continuity of clinical support throughout your medication transition, ensuring your weight management journey continues without interruption or compromised therapeutic outcomes.
Complete Switch & Save Solution: Why EverydayMeds for Wegovy Transitions
Choosing EverydayMeds for your Wegovy prescription means accessing competitive pricing with transparent bundle options, expert clinical support, and reliable medication supply that supports long-term treatment success. Our discount codes FIRST40 and DOSE25 provide immediate savings at checkout, while our range of single pens and multi-dose bundles accommodates different treatment phases and budgetary preferences. Whether you're transitioning from Mounjaro, starting fresh, or seeking cost-effective maintenance supply, our GPhC-registered service (#9012878) ensures clinical excellence and regulatory compliance. Express prescriber review, next-day cold-chain delivery, and ongoing clinical support create a comprehensive solution that prioritises both convenience and therapeutic outcomes. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover why thousands of patients trust EverydayMeds for their prescription weight management medications.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
